PRICE MICHAEL DENNIS (Chief Financial Officer) reported 1 transaction at AKCEA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/13/2020ACC: 0001209191-20-054622
Officer· Chief Financial Officer
Since May 2020
-350K
Net shares
Net seller
$907.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
350K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−50K
Price / share
$18.15
Trade value
$907.50K
% of position
New position
10/12/2020
50K→0.00
Total
Net shares
−50K
Net value
-$907.50K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/12/2020 | U · U | −50K | $18.15 | $907.50K | New position | 50K | 0.00 |
| Total | −50K | -$907.50K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
300K shares
Shares
−300K
Strike price
14.78
Held after
0.00
Exercisable
—
10/12/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock300K shares | 10/12/2020 | D · Disposition | −300K | 14.78 | — | 0.00 |